PRECISION GENOMIC CONTROL Trademark

Trademark Overview

On Wednesday, October 23, 2019, a trademark application was filed for PRECISION GENOMIC CONTROL with the United States Patent and Trademark Office. The USPTO has given the PRECISION GENOMIC CONTROL trademark a serial number of 88665753. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 27, 2023. This trademark is owned by Omega Therapeutics, Inc.. The PRECISION GENOMIC CONTROL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, multigenic disorders, hepatic disorders and disorders of the CNS, none of the foregoing including omega fatty acids

General Information

Serial Number88665753
Word MarkPRECISION GENOMIC CONTROL
Filing DateWednesday, October 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements

Goods and ServicesPharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, multigenic disorders, hepatic disorders and disorders of the CNS, none of the foregoing including omega fatty acids
NOT AVAILABLE"GENOMIC CONTROL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOmega Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameOmega Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, October 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 30, 2019ASSIGNED TO EXAMINER
Tuesday, December 31, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 31, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 31, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 29, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 29, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 29, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 21, 2021SOU EXTENSION 1 FILED
Wednesday, April 21, 2021SOU EXTENSION 1 GRANTED
Friday, April 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 26, 2021SOU EXTENSION 2 FILED
Tuesday, October 26, 2021SOU EXTENSION 2 GRANTED
Thursday, October 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2022SOU EXTENSION 3 FILED
Tuesday, April 26, 2022SOU EXTENSION 3 GRANTED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 4 FILED
Wednesday, October 26, 2022SOU EXTENSION 4 GRANTED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 26, 2023SOU EXTENSION 5 FILED
Tuesday, May 2, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 2, 2023SOU EXTENSION 5 GRANTED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 1, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, November 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

control genomic precision disease disorders hepatic diseases structure skeletal muscle renal reproductive cardiovascular